Yukio Ago

Dr. Yukio Ago

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
SKShunsuke Kataoka
Shunsuke Kataoka
KTKazuhiro Takuma
Kazuhiro Takuma
YHYuta Hara
Yuta Hara
YMYuko Maeda
Yuko Maeda
YAYukio Ago
Yukio Ago
TMToshio Matsuda
Toshio Matsuda
Maternal use of valproic acid (VPA) during pregnancy has been implicated in the aetiology of autism spectrum disorders in children, and rodents prenatally exposed to VPA showed behavioural alterations similar to those observed in humans with autism. However, the exact mechanism for VPA-induced behavioural alterations is not known. To study this point, we examined the effects of prenatal exposure to VPA and valpromide, a VPA analog lacking histone deacetylase inhibition activity, on behaviours, cortical pathology and histone acetylation levels in mice. Mice exposed to VPA at embryonic day 12.5 (E12.5), but not at E9 and E14.5, displayed social interaction deficits, anxiety-like behaviour and memory deficits at age 4–8 wk. In contrast to male mice, the social interaction deficits (a decrease in sniffing behaviour) were not observed in female mice at age 8 wk. The exposure to VPA at E12.5 decreased the number of Nissl-positive cells in the middle and lower layers of the prefrontal cortex and in the lower layers of the somatosensory cortex at age 8 wk. Furthermore, VPA exposure caused a transient increase in acetylated histone levels in the embryonic brain, followed by an increase in apoptotic cell death in the neocortex and a decrease in cell proliferation in the ganglionic eminence. In contrast, prenatal exposure to valpromide at E12.5 did not affect the behavioural, biochemical and histological parameters. Furthermore, these findings suggest that VPA-induced histone hyperacetylation plays a key role in cortical pathology and abnormal autism-like behaviours in mice.

8 June 2010 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
KKKen Koda
Ken Koda
YAYukio Ago
Yukio Ago
YCYana Cong
Yana Cong
YKYuki Kita
Yuki Kita
KTKazuhiro Takuma
Kazuhiro Takuma
TMToshio Matsuda
Toshio Matsuda

1 June 2017 in Neuron
Verified
Journal Article
Closed access
KSKaoru Seiriki
Kaoru Seiriki
AKAtsushi Kasai
Atsushi Kasai
THTakeshi Hashimoto
Takeshi Hashimoto
WSWiebke Schulze
Wiebke Schulze
MNMisaki Niu
Misaki Niu
HHHitoshi Hashimoto
Hitoshi Hashimoto

1 November 2014 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
KTKazuhiro Takuma
Kazuhiro Takuma
YHYuta Hara
Yuta Hara
SKShunsuke Kataoka
Shunsuke Kataoka
TKTakuya Kawanai
Takuya Kawanai
YMYuko Maeda
Yuko Maeda
TMToshio Matsuda
Toshio Matsuda

1 March 2013 in Neuropharmacology
Verified
Journal Article
Closed access
SCShigeyuki Chaki
Shigeyuki Chaki
YAYukio Ago
Yukio Ago
APAgnieszka Pałucha-Poniewiera
Agnieszka Pałucha-Poniewiera
FMFrancesco Matrisciano
Francesco Matrisciano
APAndrzej Pilc
Andrzej Pilc

1 December 2008 in Neuropharmacology
Verified
Journal Article
Closed access
YAYukio Ago
Yukio Ago
SAShinsuke Arikawa
Shinsuke Arikawa
MYMiyuki Yata
Miyuki Yata
KYKoji Yano
Koji Yano
MAMichikazu Abe
Michikazu Abe
TMToshio Matsuda
Toshio Matsuda